International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer


Recommended Conferences for Motor neuron diseases

Motor neuron diseases

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.

The motor neuron diseases are a group of progressive neurological disorders that destroy motor neurons, the cells that control essential voluntary muscle activity such as speaking, walking, breathing, and swallowing.  Normally, messages from nerve cells in the brain are transmitted to nerve cells in the brain stem and spinal cord and from them to particular muscles.  Upper motor neurons direct the lower motor neurons to produce movements such as walking or chewing.  Lower motor neurons control movement in the arms, legs, chest, face, throat, and tongue.  Some of the more common MNDs are as follows amyotrophic lateral sclerosis, Progressive bulbar palsy, Pseudobulbar palsy, Primary lateral sclerosis and Spinal muscular atrophy.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that ConferenceSeries hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.

Motor neuron diseases can affect any adult at any age but most people diagnosed with the disease are over the age of 40, with the highest incidence occurring between the ages of 50 and 70. Men are affected approximately twice as often as women. MND affects 4-6 people out of every 100 000. MND usually presents in middle age and is slightly more common in men. In New Zealand about 300 people have motor neurone disease at any one time. Slightly more men than women develop the disease. An estimated 1,900 people have MND in Australia, for every person diagnosed with MND it is estimated that a further 14 members of their family and their friends will live with the effect of MND forever. In 2011, 790 people with MND died compared with 592 people with MND who died in 2001. The cause of this increase is mostly unknown.

The global market for neurological disease treatment and medication was worth $12.6 billion in 2006 and will reach $14 billion by 2007. At a compound annual growth rate (CAGR) of 11.6%, the global market will be worth almost $24.3 billion by 2012. Owing to the high-impact growth drivers that outweigh the restraints, the global neuro market is forecast to reach $14 billion by 2020, registering a CAGR of 15.8% from 2014 to 2020.

Motor neuron diseases are a fatal neurodegenerative disease. It is characterized by the onset of symptoms and signs of degeneration of primarily the upper and lower motor neurones. This leads to progressive weakness of the bulbar, limb, thoracic and abdominal muscles.

Respiratory muscle weakness resulting in respiratory impairment is a major feature of MND, and is a strong predictor of quality of life and survival. Non-invasive ventilation can improve symptoms and signs related to respiratory impairment and hence survival.

There is currently no evidence-based guideline for use in England, Wales and Northern Ireland that addresses the use of non-invasive ventilation in patients with MND. This guideline considers the signs and symptoms that can be used for predicting respiratory impairment in patients with MND, the diagnostic accuracy of investigations for detecting and monitoring respiratory impairment, the clinical and cost effectiveness of non-invasive ventilation for treating respiratory impairment and the information and support needs of patients and their families and carers relating to the use of non-invasive ventilation.

The motor neuron diseases (MNDs) are a group of progressive neurological disordersthat destroys motor neurons, the cells that control essential voluntary muscle activity such as speaking, walking, breathing, and swallowing.

Some MNDs are inherited, but the causes of most MNDs are not known. In sporadic or non inherited MNDs, environmental, toxic, viral, or genetic factors may be implicated. There are no specific tests to diagnose most MNDs although there are now gene tests for SMA. Symptoms may vary among individuals and, in the early stages of the disease, may be similar to those of other diseases, making diagnosis difficult.

Electromyography (EMG) is used to diagnose disorders of lower motor neurons, as well as disorders of muscle and peripheral nerves. There is no cure or standard treatment for the MNDs. Symptomatic and supportive treatment can help people be more comfortable while maintaining their quality of life.

List of Best International Conferences

2nd   Brain Disorders Conference, October 27-29, 2016 Chicago, USA.

5th Neurology Conference, March 14-16, 2016 London, UK.

2nd Neurological Disorders and Stroke Conference April 28-30, 2016 Dubai, UAE

2nd Parkinson’s Disease and Movement Disorders Conference November 28-30, 2016 Chicago, USA

6th Neurological Conference May 19-21, 2016 San Antonio, USA

Eating Disorders Congress August 15-17, 2016 Portland, Oregon

4th Vascular Dementia Conference June 30-July 2, 2016 Valencia, Spain

5th Alzheimer’s Disease and Dementia Conference September 29-Oct 1, 2016 London, UK

2nd Sleep Disorders Conference November 28- 30, 2016 Chicago, USA

2nd Epilepsy Conference October 24-26, 2016 Rome, Italy

Autism Conference, May 5-6, 2016 Chicago, USA

National MND Conference 2014

The 25th International Symposium on ALS/MND.

XIII International Congress on Neuromuscular Diseases

The 9th International Motor neuron Meeting

20th International APPAC Conference 2015 - Association of Psychology and Psychiatry for Adults and Children

9th International Symposium on Neuroprotection and Neurorepair 2016 , Jun-16, Germany.

BIT`s 7th Annual World Congress of Neuro-Talk 2016, May-16, CHINA.   

7th Annual Spinal Disorders, Baltimore, MD, United States            

List of Related Societies:

ALS Association

Muscular Dystrophy Association

ALS Therapy Development Institute

Les Turner ALS Foundation

Motor Neuron Disease Association

Natural Herbs Clinic

The Complete Group

Virtual Medical Centre

List of Related Companies

Edtronic Inc.


Advanced Bionics AG

Boston Scientific Corporation


St. Jude Medical

Retina Implant AG


NDI Medical LLC.


This page will be updated regularly.

This page was last updated on June 2, 2023

Conference Series Destinations